The rationale for application of NSAIDs in Alzheimer's therapy

被引：0
|
作者：
Weggen, Sascha [1 ]
机构：
[1] Univ Mainz, Emmy Noether Res Grp, Inst Physiol Chem & Pathobiochem, D-55128 Mainz, Germany
来源：
ACTA PHARMACOLOGICA SINICA | 2006年 / 27卷 / 09期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：1272 / 1272
页数：1
相关论文
共 50 条
  • [1] The Rationale for Radiation Therapy in Alzheimer's Disease
    Wilson, George D.
    Rogers, C. Leland
    Mehta, Minesh P.
    Marples, Brian
    Michael, Daniel B.
    Welsh, James S.
    Martinez, Alvaro A.
    Fontanesia, James
    [J]. RADIATION RESEARCH, 2023, 199 (05) : 506 - 516
  • [2] The Rationale for Insulin Therapy in Alzheimer's Disease
    Ribaric, Samo
    [J]. MOLECULES, 2016, 21 (06):
  • [3] Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?
    Benzi, G
    Moretti, A
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 346 (01) : 1 - 13
  • [4] Rationale for combination therapy with galantamine and Memantine in Alzheimer's disease
    Grossberg, George T.
    Edwards, Keith R.
    Zhao, Qinying
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (07): : 17S - 26S
  • [5] Effect of NSAIDs on risk of Alzheimer's disease - Conclusions on NSAIDs and Alzheimer's disease were overstated
    Price, D
    [J]. BRITISH MEDICAL JOURNAL, 2003, 327 (7417): : 752 - 752
  • [6] Nasal NSAIDs for Alzheimer's Disease
    Lehrer, Steven
    [J]. AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2014, 29 (05): : 401 - 403
  • [7] NSAIDs fail Alzheimer's patients
    不详
    [J]. CHEMICAL & ENGINEERING NEWS, 2003, 81 (23) : 34 - 34
  • [8] Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimer's Disease
    Heneka, M. T.
    Kummer, M. P.
    Weggen, S.
    Bulic, B.
    Multhaup, G.
    Muenter, L.
    Huell, M.
    Pflanzner, T.
    Pietrzik, C. U.
    [J]. CURRENT ALZHEIMER RESEARCH, 2011, 8 (02) : 115 - 131
  • [9] NSAIDs and cognition in Alzheimer's disease
    Doraiswamy, PM
    Krishen, A
    Stallone, F
    Martin, ML
    Potts, NLS
    Metz, A
    DeVeaughGeiss, J
    [J]. NEUROLOGY, 1996, 46 (04) : 1194 - 1194
  • [10] Treatment of Alzheimer's disease: rationale for combination therapy with galantamine and memantine
    Zarra, J.
    Schmidt, L.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S545 - S545
12345